Sidley represented Incyte on the deal. Incyte (NASDAQ:INCY) announced its agreement to acquire Villaris Therapeutics, a biopharmaceutical company focused on the development of novel antibody therapeutics. The...
This content is for Standard 1 Year members only. LoginJoin Now